These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20137308)

  • 1. [Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].
    Wu XJ; He J; Wu DP; Sun AN; Bao XJ; Qiu QC; Yuan XN; Li WY; Chang HR; Han Y; Ma X; Zhu ZL; Xu Y; Feng YF; Dai LJ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Nov; 30(11):741-4. PubMed ID: 20137308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KIR and HLA-Cw genotypes of donor-recipient pairs influence the rate of CMV reactivation following non-T-cell deleted unrelated donor hematopoietic cell transplantation.
    Wu X; He J; Wu D; Bao X; Qiu Q; Yuan X; Han Y; Sun A; Chen G; Xu Y
    Am J Hematol; 2009 Nov; 84(11):776-7. PubMed ID: 19787798
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of recipient HLA-Cw and donor killer immunoglobulin-like receptor genotyping on the outcome of patients receiving HLA-matched sibling donor hematopoietic stem cell transplantation for myeloid malignancies.
    Wang H; He Y; Zhai WJ; Wang M; Zhou Z; Zhao YX; Feng SZ; Han MZ
    Swiss Med Wkly; 2013; 143():w13717. PubMed ID: 23299929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the behavior of NK cell KIRs of donor/recipient pairs in HLA matched unrelated allo-HSCT].
    Bao XJ; He J; Chen ZX; Wu DP; Yao L; Yuan XN; Cen JN; Qiu QC; Di WY; Zhang H; Zhang J; Zhou XH; Xu HX
    Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):510-3. PubMed ID: 18078124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].
    Wang H; Zhai WJ; Wang HH; He Y; Zhou Z; Zhao YX; Zhai WH; Zhang RL; Wang M; Feng SZ; Han MZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Oct; 31(5):533-7. PubMed ID: 19968064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of donor activating or inhibitory KIR on prognosis of unmanipulated allogeneic hematopoietic stem cell transplantation].
    Liang ZY; Ren HY; Cen XN; Qiu ZX; Wang LH; Ou JP; Li Y; Wang MJ; Wang WS; Xu WL; Dong YJ; Yin Y; Sun YH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):155-60. PubMed ID: 23484711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of killer cell immunoglobulin-like receptor genotype on outcome of hematopoietic stem cell transplantation from matched sibling.
    Elfishawi SM; Mossallam GI; El-Fattah RA; El-Haddad A; Kamel AM
    Hum Immunol; 2017 Nov; 78(11-12):684-691. PubMed ID: 28993188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of donor and recipient KIR genes and KIR ligands on the occurrence of acute graft-versus-host disease and graft survival after HLA-identical sibling hematopoietic stem cell transplantation.
    Hoseinian SA; Jafari D; Mahmoodi M; Alimoghaddam K; Ostadali M; Talebzadeh Bonakdar A; Foma AM; Yekaninejad MS; Amirzargar AA
    Turk J Med Sci; 2018 Aug; 48(4):794-804. PubMed ID: 30119155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The association of killer cell immunoglobulin like receptor gene polymorphism with cytomegalovirus infection after hematopoietic stem cell transplantation].
    Wu XJ; He J; Wu DP; Bao XJ; Xu C; Zhou HF; Sun AN; Han Y; Tang XW; Fu ZZ; Ma X
    Zhonghua Nei Ke Za Zhi; 2013 Feb; 52(2):161-5. PubMed ID: 23967614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients.
    La Nasa G; Littera R; Locatelli F; Giardini C; Ventrella A; Mulargia M; Vacca A; Orrù N; Orrù S; Piras E; Giustolisi G; Lisini D; Nesci S; Caocci G; Carcassi C
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1358-68. PubMed ID: 17950922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor selection for killer immunoglobulin-like receptors B haplotype of the centromeric motifs can improve the outcome after HLA-identical sibling hematopoietic stem cell transplantation.
    Zhou H; Bao X; Wu X; Tang X; Wang M; Wu D; He J
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):98-105. PubMed ID: 24516895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KIR2DS4 and Its Variant KIR1D Are Associated with Acute Graft-versus-Host Disease, Cytomegalovirus, and Overall Survival after Sibling-Related HLA-Matched Transplantation in Patients with Donors with KIR Gene Haplotype A.
    Wu X; Yao Y; Bao X; Zhou H; Tang X; Han Y; Ma X; Liu Y; Chen J; Zhou H; Jing S; Gu B; Xu Y; Sun A; He J; Wu D
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):220-225. PubMed ID: 26476204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia.
    Cooley S; Weisdorf DJ; Guethlein LA; Klein JP; Wang T; Marsh SG; Spellman S; Haagenson MD; Saeturn K; Ladner M; Trachtenberg E; Parham P; Miller JS
    J Immunol; 2014 May; 192(10):4592-600. PubMed ID: 24748496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of natural killer cell immunoglobulin-like receptor gene family in HLA-identical sibling].
    Zhu FM; Jiang K; Lü QF; Zhang W; He J; Xu XG; Yan LX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1276-80. PubMed ID: 18088483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].
    Dou LP; DA WM; Zhao DD; Wang C; Lu XC; Kang HY; Yan P; Wang FF; Zhu HY; Li HH; Gao CJ; Yu L
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3111-4. PubMed ID: 18269867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation.
    McQueen KL; Dorighi KM; Guethlein LA; Wong R; Sanjanwala B; Parham P
    Hum Immunol; 2007 May; 68(5):309-23. PubMed ID: 17462498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of missing KIR ligands, activating KIR genotype and haplotype on the outcome of T-cell-replete hematopoietic stem cell transplantation from HLA-identical siblings in Thai patients.
    Khanuntong S; Kuptawintu P; Upaisilpsathaporn K; Poolchareon A; Bunworasate U; Hirankarn N
    HLA; 2016 Jun; 87(6):422-31. PubMed ID: 27273744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between the genetic background of donor KIR recipient HLA and the outcomes in HLA-identical sibling HSCT].
    Ma HJ; Yin XL; Guo KY; Xiao LL; Ye X
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):91-4. PubMed ID: 16732960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
    Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
    Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.